Breast | Prostate | Colon | Endometrium | GIST | Kidney | Thyroid | Skin | Lung | Esophagus | Stomach | Breast-DCIS


IHC table: TUO Mucinous Carcinomas
IHC table: Carcinomas of Unknown Origin
IHC table: Renal Carcinomas
IHC table: Germ Cell Tumors
Fields to view based on lens diameter
Molecular and IHC Tests

Breast Carcinoma Worksheet

Specimen Data:
Procedure



Specimen Integrity

Specimen Laterality


Specimen Metrics

Tumor/Specimen Location

Carcinoma Type:














Tumor Data:
Tumor Size (invasive component):

Skeletal muscle involvement



Angiolymphatic Invasion

Skin involvement






Peau d'orange (involving less than 1/3 of breast skin)
Inflammatory carcinoma present, clinically (at least 1/3 of skin)

Tumor Grading

Tubules


Nuclei


Mitoses


Overall grade:


In Situ Carcinoma:
Presence of in situ carcinoma





Architectural patterns





Nuclear grade





Margins:
MarginInvasive TumorIn Situ Tumor














MarginInvasive TumorIn Situ Tumor














MarginInvasive TumorIn Situ Tumor















Staging
Lymph Node Status

SiteSampledPositive
(>2.0mm)
MicMets
(≤2.0mm,
>0.2mm)
ITCs
(≤0.2mm)
Sentinel lymph nodes
Axillary/intramammary nodes
Non-regional lymph nodes
Metastasis Status

Miscellaneous
Treatment Effect




Modifiers






Receptor Studies
ER-IHC
ER-IHC:
Result:
Strength:
Prior:
PR-IHC
PR-IHC:
Result:
Strength:
Prior:
Her2-IHC
Her2-IHC:
Result:
Prior:
Her2-FISH
Her2-FISH:
Result:
Prior:
Other Findings











Comments











Free-text Comments





Final Report